Representative before the EPO

Company dna forrester and boehmert
operating 1977 - 2012
2 offices
active in Legal Services

Representative before the EPO

Employment test 11 - 50 employees
Company dna forresters
operating since 1884
Headquarter in Birmingham and 5 offices
active in Legal Services and IP Consulting

Jonathan Vallance Gowshall has worked on the following 165 EPO patent applications which have been published in the last five years:

EP11708381

THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS

IPC classification:
A61K 31/137, A61P 35/00
Applicant:
Sri International Inc
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP11766786

B-CELL ANTIGEN PRESENTING CELL ASSAY

IPC classification:
G01N 33/68
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP11779044

SYSTEM AND METHOD FOR THE CONTINUOUS TREATMENT OF SOLIDS AT NON-ATMOSPHERIC PRESSURE

IPC classification:
A23L 1/0522, A23L 1/10, A23L 1/20, A47J 27/16
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP11850419

PHARMACEUTICAL FORMULATIONS CONTAINING CORTICOSTEROIDS FOR TOPICAL ADMINISTRATION

IPC classification:
A61K 31/56
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP11845227

METHOD FOR STIMULATING OSTEOGENESIS

IPC classification:
D04H 13/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11712114

HEAVY DUTY CONFIGURABLE SHEAR CRUSHER DEMOLITION TOOL

IPC classification:
B23D 17/06, E02F 3/96, E04G 23/08
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11787516

TISSUE INFUSION APPARATUS AND METHOD

IPC classification:
A61M 5/00, A61M 25/00, A61M 25/06
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12753030

PEPTIDE-LIPID CONSTRUCTS AND THEIR USE IN A FC-FUNCTION ASSAY

IPC classification:
A61K 31/683, A61K 38/16, A61K 39/385, C07F 9/10, C07K 14/00, C07K 14/045, C07K 17/06, G01N 33/53, G01N 33/531, G01N 33/536, G01N 33/555, G01N 33/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12759932

MICROBIAL PRODUCTION OF CHEMICAL PRODUCTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS

IPC classification:
C12P 1/00
Agent:
Multiple attorneys, Avidity IP Ltd
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP12765325

GENE EXPRESSION PREDICTORS OF CANCER PROGNOSIS

IPC classification:
C12Q 1/68, G01N 33/50
Applicant:
Oregon Health & Science University
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12768032

BIO-BASED BINDERS INCLUDING CARBOHYDRATES AND A PRE-REACTED PRODUCT OF AN ALCOHOL OR POLYOL AND A MONOMERIC OR POLYMERIC POLYCARBOXYLIC ACID

IPC classification:
C09D 103/02, D04H 13/00
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Cass A.C. Dottridge, Cargill Europe bvba
Status:
EXAMINATION IN PROGRESS
EP12717009

HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR GLYPICAN-3 AND USE THEREOF

IPC classification:
C07K 16/30
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12726986

ADIPOSE TISSUE MATRICES

IPC classification:
A61L 27/36, A61L 27/56, A61L 27/58
Applicant:
Lifecell Corporation
Agent:
Multiple attorneys, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP12735414

P97-ANTIBODY CONJUGATES AND METHODS OF USE

IPC classification:
A61K 47/48, A61P 35/00, C12N 9/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12802203

SELF-RENEWING ENDODERMAL PROGENITOR LINES GENERATED FROM HUMAN PLURIPOTENT STEM CELLS AND METHODS OF USE THEREOF

IPC classification:
C12N 5/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12802232

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR H1N1 INFLUENZA

IPC classification:
C12N 15/33, C12N 15/44, C12N 15/63
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
PATENT GRANTED
EP12741191

METHODS AND COMPOSITIONS FOR INHIBITING POLYOMAVIRUS-ASSOCIATED PATHOLOGY

IPC classification:
C07K 16/08
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12833937

METHODS AND COMPOSITIONS FOR EXPANDING CELLS AND IMPROVING ENGRAFTMENT

IPC classification:
A61L 27/38, C12N 5/071, C12N 5/074, C12N 15/63, G01N 33/50
Applicant:
University of Louisville Research Foundation, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12746240

P97 FRAGMENTS WITH TRANSFER ACTIVITY

IPC classification:
A61K 38/40, C07K 14/79
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP12782865

SYSTEMS AND METHODS FOR INDIVIDUALIZED FUNCTIONAL GENOMIC PROFILIING RELATED TO CANCER CELL GROWTH

IPC classification:
C12M 1/34, C12Q 1/68
Agent:
Pfennig Meinig & Partner GbR
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12761841

INFLUENZA VIRUSES WITH MUTANT PB2 GENE SEGMENT AS LIVE ATTENUATED VACCINES

IPC classification:
A61K 39/145, C12N 7/00, G01N 33/569
Applicant:
Wisconsin Alumni Research Foundation (WARF)
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP11816943

METHODS AND COMPOSITIONS FOR PREVENTING A CONDITION

IPC classification:
A61K 31/713, A61K 39/00, A61P 25/00, A61P 33/06, A61P 35/00, C12N 15/62
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12841840

IMPROVED METHOD AND APPARATUS FOR GROWING SPROUTS

IPC classification:
A01C 1/00, A01C 1/02
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12780376

N-DEMETHYASE GENES AND USES THEREOF

IPC classification:
C12N 1/19, C12N 1/21, C12N 9/00, C12N 15/53, C12P 17/18, C12Q 1/26
Applicant:
University of Iowa Research Foundation
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14163233

Prediction of likelihood of cancer recurrence

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Williams Powell
Status:
PATENT GRANTED
EP12847964

METHOD OF PREDICTING BREAST CANCER PROGNOSIS

IPC classification:
C12Q 1/68, G01N 33/50
Agent:
Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12847241

NEUTRALIZING GP41 ANTIBODIES AND THEIR USE

IPC classification:
A61K 39/42, A61P 31/18, C07K 16/10, C12N 15/13
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP11773933

MACHINE AND METHOD FOR HAIR OR BRISTLE REMOVAL

IPC classification:
A22B 5/08, A22B 5/10, A22C 13/00, A45D 26/00
Applicant:
Lifecell Corporation
Agent:
Multiple attorneys, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP12806795

COMPOSITIONS AND METHODS FOR ENHANCED GENERATION OF HEMATOPOIETIC STEM/PROGENITOR CELLS

IPC classification:
A61K 35/12, C12N 5/0789
Applicant:
Novartis Institute for Functional Genomics, Inc.
Applicant:
Novartis AG
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jones Day
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12855597

NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE

IPC classification:
A61K 39/42, A61P 31/18, C07K 16/10, C12N 15/13, G01N 33/569
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12858324

CONTROL AND DELIVERY OF ELECTRIC FIELDS VIA AN ELECTRODE ARRAY

IPC classification:
A61B 18/18
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12880480

BIOCOMPATIBLE METHOD OF FUNCTIONALISING SUBSTRATES WITH INERT SURFACES

IPC classification:
G01N 33/48, G01N 33/53, G01N 33/543
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12849133

PROCESSES AND SYSTEMS FOR NON-EQUILIBRIUM TRICHLOROSILANE PRODUCTION

IPC classification:
B01J 6/00, B01J 23/26, B01J 23/755, C01B 33/107
Applicant:
SiTec GmbH
Agent:
Multiple attorneys, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14163244

Gene expression profiling in biopsied tumor tissues

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Williams Powell
Status:
PATENT GRANTED
EP11712392

SEVERE DUTY GRAPPLE WITH TUBULAR PIVOT

IPC classification:
B66C 3/04, E02F 3/413, F16C 11/04
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13738804

TOPICAL THERAPEUTIC FORMULATIONS

IPC classification:
A61K 31/4422, A61K 35/12, A61K 38/44, A61P 17/00, A61P 19/04
Agent:
Pfennig Meinig & Partner GbR
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13744228

PROMOTING TRANSCRANIAL DIRECT CURRENT STIMULATION OR TRANSCRANIAL MAGNETIC STIMULATION USING TEMPERATURE-INDUCED SYNAPTIC MODULATION

IPC classification:
A61N 1/04, A61N 1/20, A61N 2/02
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13747212

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR H3N2, H2N2, AND B INFLUENZA VIRUSES

IPC classification:
A61K 39/145, A61P 31/16, C07K 14/11, C12N 15/44
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13749680

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR HUMAN AND AVIAN H5N1 INFLUENZA

IPC classification:
A61K 39/145, A61P 31/16, C07K 14/11, C12N 15/44, C12N 15/63
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12799947

TEM8 ANTIBODIES, CONJUGATES THEREOF, AND THEIR USE

IPC classification:
C07K 16/28, C07K 16/30
Applicant:
Novartis AG
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13713301

SOLUBLE ENGINEERED MONOMERIC FC

IPC classification:
C07K 16/00, C07K 16/10
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13763664

NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE

IPC classification:
A61K 39/42, A61P 31/18, C07K 16/10
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13769077

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR H5N1 AND H1N1 INFLUENZA VIRUSES

IPC classification:
A61K 31/16, A61K 39/145, C07K 14/11, C12N 15/44
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13834351

COMPOSITIONS COMPRISING S-ADENOSYLMETHIONINE AND A GALLIC ACID ESTER

IPC classification:
A61K 9/20, A61K 9/28, A61K 9/48, A61K 31/235, A61K 31/7076, A61K 45/06, A61K 47/14, A61P 1/16, A61P 19/02, A61P 25/00, A61P 29/00, A61P 35/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11845757

METHODS FOR TREATING A TUMOR USING AN ANTIBODY THAT SPECIFICALLY BINDS GRP94

IPC classification:
A61K 31/437, A61K 35/00, A61K 39/00, A61K 39/395, A61K 45/06, C07K 16/18, C07K 16/30
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP11797397

EPOXY COMPOSITE

IPC classification:
B29B 7/84, B29B 7/90, B29C 70/02, B29C 70/66, B29K 63/00, B29K 105/16, C08L 63/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12881774

HIGHLY MULTIPLEX PCR METHODS AND COMPOSITIONS

IPC classification:
C12Q 1/68
Agent:
Philip Michael Webber, Dehns Ltd
Agent:
Multiple attorneys, Forresters IP LLP
Status:
PATENT GRANTED
EP14195969

Compositions and methods for treating diseases of the nail

IPC classification:
A61K 31/454, A61K 31/675, A61K 47/10, A61K 47/14, A61K 47/24, C07F 9/06
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13727753

METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES

IPC classification:
A61K 31/05, A61K 45/06, A61P 35/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14185860

Impregnated odour control products and methods of making the same

IPC classification:
A01N 25/10, A01N 25/34, A01N 63/00, A43B 1/00, A43B 13/12, A63B 21/00, C08K 5/00, C12N 1/20, C12N 3/00, D01F 1/10
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14189399

Mutation in OAS1 genes

IPC classification:
A61K 38/16, C12N 9/12, C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13712625

METHODS AND COMPOSITIONS FOR DETECTION OF LEGIONELLA

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13713612

CAFFEINE RESPONSIVE PROMOTERS AND REGULATORY GENES

IPC classification:
C12N 15/63
Applicant:
University of Iowa Research Foundation
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13806393

METHOD FOR OBTAINING FETAL CELLS AND FETAL CELLULAR COMPONENTS

IPC classification:
A61B 10/00, A61B 10/02, C12N 5/073, G01N 33/50
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP11825727

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR INFLUENZA

IPC classification:
A61K 39/145, C12N 15/33, C12N 15/44, C12N 15/63
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13737939

TISSUE-BASED DRAIN MANIFOLDS

IPC classification:
A61L 31/04, A61M 27/00
Applicant:
Lifecell Corporation
Agent:
Multiple attorneys, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13745754

MACROPOROUS CATHETER

IPC classification:
A61B 5/00, A61B 5/145, A61B 10/00, A61L 29/00, A61M 1/28, A61M 25/00, A61M 27/00, A61M 31/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP11858061

METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING

IPC classification:
C12Q 1/68, G01N 33/48, G06F 19/18, G06F 19/22
Agent:
Philip Michael Webber, Dehns Ltd
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13747600

DEPHOSPHORYLATED LYSOSOMAL STORAGE DISEASE PROTEINS AND METHODS OF USE THEREOF

IPC classification:
A61K 38/46, A61K 47/48, C12N 9/16
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13829596

METHODS AND COMPOSITIONS FOR REDUCING GENETIC LIBRARY CONTAMINATION

IPC classification:
C07H 21/04, C12P 19/34, C40B 30/04, C40B 40/06, C40B 40/08
Agent:
Philip Michael Webber, Dehns Ltd
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11784180

METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING

IPC classification:
C12Q 1/68, G06F 19/18, G06F 19/22
Agent:
Philip Michael Webber, Dehns Ltd
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13753475

MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF

IPC classification:
A61K 47/48, C07K 16/30
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13835916

METHODS FOR INCREASING FETAL FRACTION IN MATERNAL BLOOD

IPC classification:
C40B 20/00
Agent:
Philip Michael Webber, Dehns Ltd
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14195468

Methods for non-invasive prenatal ploidy calling

IPC classification:
C12Q 1/68
Agent:
Multiple attorneys, Forresters IP LLP
Status:
PATENT GRANTED
EP13766859

MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/30
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP15158222

Edge coatings for adhesive tapes

IPC classification:
C09J 7/02, C09J 7/04
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15152517

Method for using gene expression to determine prognosis of prostate cancer

IPC classification:
C12Q 1/68, G01N 33/574
Agent:
Multiple attorneys, Forresters IP LLP
Agent:
Williams Powell
Status:
PATENT GRANTED
EP15162282

Brachyury polypeptides and methods for use

IPC classification:
A61K 39/00, C07K 4/12, C07K 14/47, C07K 14/82, C12N 15/113, G01N 33/569, G01N 33/574
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13855449

TREATMENT OF POST-TRAUMATIC STRESS DISORDER USING BOTULINUM TOXIN A

IPC classification:
A61K 39/08
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13855135

SURGICAL SYSTEM

IPC classification:
A61B 19/02
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13857490

INHIBITORS OF THE T CELL-SPECIFIC ALTERNATIVE P38 ACTIVATION PATHWAY AND METHODS OF USE

IPC classification:
A61K 38/10, A61P 37/00, C07K 7/08, C07K 19/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13859229

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR H1N1 INFLUENZA

IPC classification:
A61K 38/16, A61K 39/145, C07K 14/11, C12N 15/44
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13863944

ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS

IPC classification:
A61K 39/395
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14737656

COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE

IPC classification:
C12N 5/0783
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14702339

COMPOSITIONS AND METHODS FOR EXPANSION OF EMBRYONIC HEMATOPOIETIC STEM CELLS

IPC classification:
A61K 35/28, C12N 5/0789
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jones Day
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15173816

GENE EXPRESSION MARKERS FOR PREDICTING RESPONSE TO CHEMOTHERAPY

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
PATENT GRANTED
EP15162054

COMPOSITIONS COMPRISING S-ADENOSYLMETHIONINE AND A GALLIC ACID ESTER

IPC classification:
A61K 9/20, A61K 9/28, A61K 9/48, A61K 31/235, A61K 31/7076, A61K 45/06, A61K 47/14, A61P 1/16, A61P 19/02, A61P 25/00, A61P 29/00, A61P 35/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14706762

COMPOSITIONS AND METHODS FOR TREATING AND REPAIRING TENDONS

IPC classification:
A61K 35/36, C12N 5/077, C12N 5/0775
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14754421

METHODS OF SEQUENCING NUCLEIC ACIDS IN MIXTURES AND COMPOSITIONS RELATED THERETO

IPC classification:
C12N 15/10, C12Q 1/68
Applicant:
Emory University
Applicant:
Johns Hopkins University
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15170077

DECELLULARIZATION AND RECELLULARIZATION OF ORGANS AND TISSUES

IPC classification:
A61K 9/00, A61K 35/12, A61K 35/34, A61M 1/10, C12M 1/12, C12M 1/26, C12M 3/00, C12N 5/071
Applicant:
Regents of the University of Minnesota
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14716493

FRAGMENTS OF P97 AND USES THEREOF

IPC classification:
C07K 14/79
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14763713

ACTIVATED CARBON FILTRATION FOR PURIFICATION OF BENZODIAZEPINE ADCs

IPC classification:
A01N 43/62, A61K 31/55, A61K 39/00, B01D 15/04, C02F 1/28, C07D 243/12
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14778142

CYCLODEXTRIN AND ANTIBODY-DRUG CONJUGATE FORMULATIONS

IPC classification:
A01N 43/04, A61K 39/00, C07D 487/00, C07K 16/00
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14763831

ACETYL-COA CARBOXYLASE MUTATIONS

IPC classification:
C12N 1/21, C12N 9/00, C12N 15/52
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14768529

COMPOSITIONS AND METHODS TO MODIFY CELLS FOR THERAPEUTIC OBJECTIVES

IPC classification:
C12N 15/62
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14783418

CHIMERIC ADENO-ASSOCIATED VIRUS/ BOCAVIRUS PARVOVIRUS VECTOR

IPC classification:
A61K 39/23
Applicant:
University of Kansas
Applicant:
University of Iowa Research Foundation
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Pfizer Inc
Status:
EXAMINATION REQUESTED
EP13881946

DEMOLITION SHEAR AND DEMOLITION SHEAR PIERCING TIP INSERT AND NOSE CONFIGURATION

IPC classification:
B23D 35/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14723540

DEVICES AND METHODS FOR TREATING FUNCTIONAL TRICUSPID VALVE REGURGITATION

IPC classification:
A61F 2/24
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14764077

STEVIA PLANTS WITH AN INCREASED REBAUDIOSIDE D CONTENT

IPC classification:
A01H 5/00
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14724976

LONE STAR VIRUS

IPC classification:
C07K 14/175, C07K 16/10, C12N 7/00, G01N 33/569
Applicant:
The Regents of the University of California
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14794851

IN SITU MIXING AND APPLICATION OF HYDROCOLLOID SYSTEMS FOR PRE-AND POST HARVEST USE ON AGRICULTURAL CROPS

IPC classification:
A01N 25/00
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14727696

SINGLE-DOMAIN VHH ANTIBODIES DIRECTED TO NOROVIRUS GI.1 AND GII.4 AND THEIR USE

IPC classification:
A61K 39/395, A61P 31/12, A61P 31/14, C07K 16/08, C07K 16/10, G01N 33/569
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP15188264

HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR GLYPICAN-3 AND USE THEREOF

IPC classification:
A61K 39/00, A61K 39/395, A61K 47/48, C07K 16/28, C07K 16/30, G01N 33/574, G01N 33/68
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14798331

ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO THE CENTRAL NERVOUS SYSTEM

IPC classification:
A01N 63/00, C12N 15/00, C12N 15/86
Applicant:
Regents of the University of Minnesota
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14728395

COMPOUNDS FOR INHIBITING DRUG-RESISTANT STRAINS OF HIV-1 INTEGRASE

IPC classification:
A61K 31/4375, A61K 31/4704, A61K 31/496, A61K 31/5377, A61K 45/06, C07D 471/04
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP12190270

Detection of infectious prion protein by seeded conversion of recombinant prion protein

IPC classification:
G01N 33/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14803477

CONOTOXIN PEPTIDES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 38/10
Applicant:
University of Utah Research Foundation
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP15195219

METHODS FOR PREPARING COMPLEX MULTIVALENT IMMUNOGENIC CONJUGATES

IPC classification:
A61K 39/00, A61K 39/08, A61K 39/095, A61K 39/385, A61K 47/48
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP11796394

ANTIBODIES TO ENDOPLASMIN AND THEIR USE

IPC classification:
A61K 39/00, C07K 16/18, C07K 16/30, G01N 33/574
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
PATENT GRANTED
EP14735030

ENCIRCLING IMPLANT DELIVERY SYSTEMS AND METHODS

IPC classification:
A61F 2/24
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP15199388

SYSTEM AND METHOD FOR CLEANING NOISY GENETIC DATA AND USING DATA TO MAKE PREDICTIONS

IPC classification:
G06F 19/18, G06F 19/22, G06F 19/24
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14737128

COMPOSITIONS AND METHODS FOR TREATING SKIN

IPC classification:
A61K 35/36, A61P 17/00, C12N 5/071
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14817352

DEVICES, SYSTEMS AND METHODS FOR MONITORING KNEE REPLACEMENTS

IPC classification:
A61B 5/103, A61B 17/56, A61F 2/38, A61F 2/46, A61F 2/48
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14745037

PHOTOACTIVATABLE LIPID-BASED NANOPARTICLES AS VEHICLES FOR DUAL AGENT DELIVERY

IPC classification:
A61K 41/00, A61K 47/48, A61P 35/00
Applicant:
Baylor College of Medicine
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP12755058

IN VIVO METHODS OF MONITORING BIODISTRIBUTION

IPC classification:
A61K 51/04, A61K 51/06, A61K 51/08, C07F 9/09, C07F 9/10
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14745060

HIGH TITER RECOMBINANT INFLUENZA VIRUSES WITH ENHANCED REPLICATION IN MDCK OR VERO CELLS OR EGGS

IPC classification:
C12N 7/00
Applicant:
Wisconsin Alumni Research Foundation (WARF)
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP11717077

COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION

IPC classification:
A61K 35/14, A61K 35/44, A61K 35/50, A61P 7/00, A61P 35/02, C07K 16/28, C12N 5/0797
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jones Day
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION WITHDRAWN
EP11717379

COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION WITHOUT HLA MATCHING

IPC classification:
A61K 35/14, A61K 35/44, A61K 35/50, A61P 7/00, A61P 35/02, C07K 16/28, C12N 5/0797
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jones Day
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION WITHDRAWN
EP13812266

TRANSVASCULAR AND TRANSCAMERAL DEVICE ACCESS AND CLOSURE

IPC classification:
A61B 17/00, A61B 17/12
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP15191753

HUMAN FACILITATING CELLS AND USES THEREOF

IPC classification:
A61K 35/12, A61P 37/00, C12N 5/071, C12N 5/0789
Applicant:
University of Louisville Research Foundation, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14845373

COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS

IPC classification:
A61K 31/165, A61P 9/12, A61P 13/12, C07C 233/11
Agent:
Multiple attorneys, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP15202562

BRASSICA PLANTS YIELDING OILS WITH A LOW TOTAL SATURATED FATTY ACID CONTENT

IPC classification:
A01H 1/00, A01H 5/10
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION PUBLISHED
EP14790440

DETECTION OF HEPATITIS DELTA VIRUS (HDV) FOR THE DIAGNOSIS AND TREATMENT OF SJÖGREN'S SYNDROME AND LYMPHOMA

IPC classification:
C12Q 1/68, C12Q 1/70
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14854262

VASCULAR DILATORS

IPC classification:
A61M 25/01, A61M 25/04, A61M 29/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13165713

Trimeric OX40-immunoglobulin fusion protein and methods of use

IPC classification:
A61K 39/39, A61K 45/00, C07K 14/52, C12P 21/02
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
PATENT GRANTED
EP14855615

METHODS OF DETERMINING BREAST CANCER PROGNOSIS

IPC classification:
C12Q 1/68, G01N 33/53
Applicant:
Oregon Health & Science University
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP11778453

MOUNTING FIXTURE FOR FIRE-RATED STRUCTURALLY GLAZED GLASS

IPC classification:
E06B 3/54, E06B 5/16
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
PATENT GRANTED
EP14858957

METHODS OF INCORPORATION OF TRANSCRIPT CHROMOSOMAL LOCUS INFORMATION FOR IDENTIFICATION OF BIOMARKERS OF DISEASE RECURRENCE RISK

IPC classification:
G06F 19/26
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP13163877

Tofa analogs useful in treating dermatological disorders or conditions

IPC classification:
A61K 31/341, A61P 17/00, C07D 307/68, C07D 405/12, C07D 407/12
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16166924

HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR GLYPICAN-3 AND USE THEREOF

IPC classification:
A61K 39/00, A61K 39/395, A61K 47/48, C07K 16/28, C07K 16/30, G01N 33/574, G01N 33/68
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14803025

TREATMENT OF SOCIAL ANXIETY DISORDER, OBSESSIVE COMPULSIVE DISORDER AND PANIC DISORDER USING BOTULINUM TOXIN

IPC classification:
A61K 31/00, A61K 38/48, A61P 25/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP11776927

METHODS OF RECELLULARIZING A TISSUE OR ORGAN FOR IMPROVED TRANSPLANTABILITY

IPC classification:
A61L 27/36, A61L 27/38
Applicant:
Regents of the University of Minnesota
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14863286

ALLELES MODIFYING BRASSICA PLANT TOTAL SATURATED FATTY ACID CONTENT

IPC classification:
A01H 5/00, G01N 33/48, G01N 33/50
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14812375

ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE

IPC classification:
A61K 48/00, C12N 9/16, C12N 15/86
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Applicant:
University of Florida Research Foundation, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14863650

PREPARING ANTIBODIES FROM CHO CELL CULTURES FOR CONJUGATION

IPC classification:
A61K 39/395, A61K 47/48, C07K 1/14
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14831120

MULTI-EPITOPE TARP PEPTIDE VACCINE AND USES THEREOF

IPC classification:
A61K 39/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14871434

METHYLENE CARBAMATE LINKERS FOR USE WITH TARGETED-DRUG CONJUGATES

IPC classification:
A61K 47/48
Applicant:
Seattle Genetics, Inc.
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP16166020

P97-ANTIBODY CONJUGATES

IPC classification:
A61K 45/06, A61K 47/48, A61P 35/00, C07K 14/79, C07K 16/32, C12N 9/00, C12N 9/14
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP16157419

ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1.3 POTASSIUM CHANNELS

IPC classification:
A61K 38/00
Applicant:
The Regents of the University of California
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION PUBLISHED
EP16162911

COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION

IPC classification:
A61K 35/14, A61K 35/44, A61K 35/50, A61P 7/00, A61P 35/02, C07K 16/28, C12N 5/0797
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION PUBLISHED
EP16166225

COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION WITHOUT HLA MATCHING

IPC classification:
A61K 35/14, A61K 35/44, A61K 35/50, A61P 7/00, A61P 35/02, C07K 16/28, C12N 5/0797
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16176482

METHOD FOR STERILISING DERMIS

IPC classification:
A61K 35/12
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15748980

HYDROPHILIC ANTIBODY-DRUG CONJUGATES

IPC classification:
A61K 38/08
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15708639

HIV-2 NUCLEIC ACIDS AND METHODS OF DETECTION

IPC classification:
C07K 14/16, C12Q 1/70
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP16181799

GENE EXPRESSION PROFILING IN BIOPSIED TUMOR TISSUES

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15758457

EASILY DISPERSIBLE FORMULATIONS OF PIGMENTS AND THEIR USE IN TINTING BASE MEDIA

IPC classification:
C09B 67/00, C09C 3/08, C09C 3/10, C09D 5/02
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15762002

MULTIPLE PANEL SUTURE DISPENSING CARD AND METHOD FOR USING THE SAME

IPC classification:
A61B 17/06
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15712513

SYSTEM WITH AN ELECTROMAGNETIC FIELD GENERATOR WITH COILS FOR TREATING TUMORS AND A METHOD FOR TREATING TISSUE

IPC classification:
A61N 1/40, A61N 2/02
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15775944

OPTIMAL DOSING OF A CD19-ANTIBODY DRUG CONJUGATE

IPC classification:
A61K 39/395, A61K 47/42, C07K 16/28
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15776984

STABLE FORMULATIONS FOR ANTI-CD19 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

IPC classification:
A61K 39/00
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP16195347

METHOD FOR USING GENE EXPRESSION TO DETERMINE PROGNOSIS OF PROSTATE CANCER

IPC classification:
C12Q 1/68, G01N 33/574
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION PUBLISHED
EP15729698

EXPANSION AND ENGRAFTMENT OF STEM CELLS USING NOTCH 1 AND/OR NOTCH 2 AGONISTS

IPC classification:
C12N 5/0789
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15747597

BLOCKING CD38 USING ANTI-CD38 F(AB')2 TO PROTECT NK CELLS

IPC classification:
A61K 39/395, A61P 35/00, A61P 37/00, C07K 16/28
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15727783

LILRB2 AND NOTCH-MEDIATED EXPANSION OF HEMATOPOIETIC PRECURSOR CELLS

IPC classification:
C12N 5/0789
Applicant:
The Board of Regents of the University of Texas System
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15812631

DEVICES, SYSTEMS AND METHODS FOR USING AND MONITORING IMPLANTS

IPC classification:
A61F 2/12
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15811456

DEVICES, SYSTEMS AND METHODS FOR USING AND MONITORING HEART VALVES

IPC classification:
A61F 2/24
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15745058

AEROSOL PARTICLE GROWTH SYSTEMS USING POLYMER ELECTROLYTE MEMBRANES

IPC classification:
G01N 15/06
Applicant:
Regents of the University of Minnesota
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP16196459

PREDICTION OF LIKELIHOOD OF CANCER RECURRENCE

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION PUBLISHED
EP15829509

INJECTION DEVICES

IPC classification:
A61M 5/315
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15839012

BOTULINUM TOXIN AND COLLOIDAL SILVER PARTICLES

IPC classification:
A61K 8/06, A61K 9/19, A61K 33/38, A61K 47/02
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15766697

RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE

IPC classification:
A61K 39/21, C07K 14/16, C12N 5/10, C12N 15/49
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15839347

TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES

IPC classification:
A61K 45/06, C07K 7/02
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15842678

DEVICES, SYSTEMS AND METHODS FOR USING AND MONITORING MEDICAL DEVICES

IPC classification:
G06F 15/173
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16201265

TISSUE SCAFFOLDS

IPC classification:
A61L 27/36
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP15849315

METHODS AND COMPOSITIONS FOR INCREASING THE POTENCY OF ANTIFUNGAL AGENTS

IPC classification:
A61P 31/10, C07C 33/22
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made

Please Sign in to use this feature